Thyroid hormone autoantibodies (THAA) in two cases of Graves' disease: effects of antithyroid drugs, prednisolone, and subtotal thyroidectomy. 1986

S Nakamura, and S Sakata, and H Shima, and T Komaki, and N Kojima, and K Kamikubo, and K Yasuda, and K Miura

Changes in titers of serum thyroid hormone autoantibodies (THAA) and anti-thyroglobulin (Tg) antibodies during treatment with antithyroid drugs (methimazole and propylthiouracil) were examined in two cases of Graves' disease. Effects of prednisolone and subtotal thyroidectomy were also investigated in one case (case 1). Initially both cases had only anti-T4 autoantibodies in their serum. During methimazole therapy, the titer of anti-T4 autoantibodies increased in both cases, and anti-T3 autoantibodies became detectable and their titer increased in case 2. The influence of propylthiouracil on the titer of THAA was not clear. Both prednisolone plus methimazole therapy and subtotal thyroidectomy decreased the level of anti-T4 autoantibodies in case 1. There was a significant correlation between titers of THAA and anti-Tg antibodies in both cases, although titers of anti-Tg antibodies in case 1 stayed within the normal range throughout the investigation period. These results indicate that methimazole treatment could induce and/or enhance the production of THAA and THAA are antibodies against thyroid hormone-containing Tg molecule.

UI MeSH Term Description Entries
D008713 Methimazole A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. Methymazol,Thiamazole,1-Methyl-2-mercaptoimidazole,Favistan,Mercasolyl,Mercazol,Mercazole,Mercazolyl,Merkazolil,Methizol,Methylmercaptoimidazole,Metisol,Metizol,Strumazol,Tapazole,Thiamazol Henning,Thiamazol Hexal,Thimazol,Thyrozol,Tiamazol,Tirodril,1 Methyl 2 mercaptoimidazole,Henning, Thiamazol,Hexal, Thiamazol
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011441 Propylthiouracil A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534) 6-Propyl-2-Thiouracil,6 Propyl 2 Thiouracil
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D013954 Thyroglobulin

Related Publications

S Nakamura, and S Sakata, and H Shima, and T Komaki, and N Kojima, and K Kamikubo, and K Yasuda, and K Miura
November 1989, Nihon Naibunpi Gakkai zasshi,
S Nakamura, and S Sakata, and H Shima, and T Komaki, and N Kojima, and K Kamikubo, and K Yasuda, and K Miura
August 1999, Thyroid : official journal of the American Thyroid Association,
S Nakamura, and S Sakata, and H Shima, and T Komaki, and N Kojima, and K Kamikubo, and K Yasuda, and K Miura
March 2017, Prescrire international,
S Nakamura, and S Sakata, and H Shima, and T Komaki, and N Kojima, and K Kamikubo, and K Yasuda, and K Miura
May 1988, Journal of endocrinological investigation,
S Nakamura, and S Sakata, and H Shima, and T Komaki, and N Kojima, and K Kamikubo, and K Yasuda, and K Miura
February 1991, Nihon Naibunpi Gakkai zasshi,
S Nakamura, and S Sakata, and H Shima, and T Komaki, and N Kojima, and K Kamikubo, and K Yasuda, and K Miura
May 1981, Archives of surgery (Chicago, Ill. : 1960),
S Nakamura, and S Sakata, and H Shima, and T Komaki, and N Kojima, and K Kamikubo, and K Yasuda, and K Miura
December 1983, Surgery,
S Nakamura, and S Sakata, and H Shima, and T Komaki, and N Kojima, and K Kamikubo, and K Yasuda, and K Miura
March 1999, Thyroid : official journal of the American Thyroid Association,
S Nakamura, and S Sakata, and H Shima, and T Komaki, and N Kojima, and K Kamikubo, and K Yasuda, and K Miura
January 2012, Endocrine journal,
S Nakamura, and S Sakata, and H Shima, and T Komaki, and N Kojima, and K Kamikubo, and K Yasuda, and K Miura
July 1996, Drug safety,
Copied contents to your clipboard!